Nozzle unit and dispenser
US-9446207-B2 · Sep 20, 2016 · US
US10016582B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10016582-B2 |
| Application number | US-201414292481-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 30, 2014 |
| Priority date | Feb 7, 2008 |
| Publication date | Jul 10, 2018 |
| Grant date | Jul 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present application discloses devices and methods for delivering a therapeutic compound to the olfactory epithelium of an animal or human. The device having one or more channels for imparting a circumferential and axial velocity to the discharged fluid, and an outlet that discharges an aerosol spray having a circumferential and axial velocity as it enters the nasal cavity of a user. The device is designed to displace the air in the upper nasal cavity in order to specifically deposit a therapeutic agent on the olfactory epithelium while minimizing pressure and discomfort experienced by the user.
Opening claim text (preview).
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A pressurized olfactory drug delivery device comprising: (a) a container comprising a mixture of a pressurized fluid and a therapeutic compound, the container at a distal end of the pressurized olfactory drug delivery device; (b) a nozzle delivery device defining a longitudinal axis and having: (i) an inner axial member having a cylindrical core, (ii) a plurality of helical channels, the helical channels having a radial dimension, a basal surface, and an apical surface, wherein the basal surface is in contact with an outer surface of the axial member, and (iii) an outer cylindrical member in contact with the apical surface of the helical channels, and (c) a metering device configured for selectively discharging the mixture of a pressurized fluid and a therapeutic compound through the helical channels; wherein each helical channel comprises an inlet for receiving the mixture of a pressurized fluid and a therapeutic compound, and an outlet for discharging the mixture of a pressurized fluid and a therapeutic compound, the outlets being located at a proximal-most end of the pressurized olfactory drug delivery device, each outlet is configured to produce an aerosol spray having an axial velocity and circumferential velocity, such that the axial velocity and the circumferential velocity produced by each outlet converge into a single spray plume having a circumferential velocity. 2. The pressurized olfactory drug delivery device of claim 1 , further comprising a conical extension, the conical extension located at the proximal-most end of the pressurized olfactory drug delivery device and congruent with the inner axial member. 3. The pressurized olfactory drug delivery device of claim 1 , wherein the helical channels spiral around the longitudinal axis. 4. The pressurized olfactory drug delivery device of claim 1 , wherein the therapeutic compound comprises at least one of small molecules, peptides, proteins, antibodies, antibody fragments, aptamers, or nucleic acids. 5. The pressurized olfactory drug delivery device of claim 1 , wherein the device delivers liquid or lyophilized therapeutic compounds. 6. The pressurized olfactory drug delivery device of claim 1 , wherein the therapeutic compound is delivered as a formulation comprising stabilizers, preservatives, or additives. 7. The pressurized olfactory drug delivery device of claim 1 , wherein the therapeutic compound is delivered as a formulation comprising colloids, nanoparticles, liposomes, or micelles.
Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008}) · CPC title
Inhaling devices inserted into the nose · CPC title
of the injector type · CPC title
producing a swirling discharge · CPC title
the outlet orifices for jets constituted by a liquid or a mixture containing a liquid being disposed on a circle · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.